Neutralizing GDF8 epitope-based growth enhancing vaccine
US7371726B2 · kind B2 · utility
22Cited by
20References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2004 |
| Grant date | May 13, 2008 |
| Priority date | — |
| Expiry date | Nov 3, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides new, specific antigenic peptides from the protein GDF8. The invention also provides fusion proteins comprising the new peptides, immunogens and vaccines based on the new peptides and/or fusion proteins, antibodies that specifically bind to the new peptides of GDF8, and methods of treating animals in order to modulate the activity of GDF8, employing vaccines or antibodies according to the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.